Abstract
An improved and scalable process for the production of rivastigmine tartrate is reported. The improved process provides rivastigmine tartrate at considerably lower cost and allows the omission of hazardous chemicals. The overall yield is increased from 4.66% (reported process) to 17% with the improved process.
Keywords: Rivastigmine tartrate, a cholinesterase inhibitor, alzheimer's disease, improved process, impurities
Letters in Organic Chemistry
Title: An Improved Process for the Production of Rivastigmine Tartrate, a Cholinesterase Inhibitor
Volume: 7 Issue: 2
Author(s): Vajrala Venkata Reddy, Mandava Venkata Naga Brahmeswara Rao, Varanasi Ganesh, Adla Vijaya Kumar, Cherukupally Praveen, Khagga Mukkanti, Ganta Mahesh Reddy and Ganta Madhusudhan Reddy
Affiliation:
Keywords: Rivastigmine tartrate, a cholinesterase inhibitor, alzheimer's disease, improved process, impurities
Abstract: An improved and scalable process for the production of rivastigmine tartrate is reported. The improved process provides rivastigmine tartrate at considerably lower cost and allows the omission of hazardous chemicals. The overall yield is increased from 4.66% (reported process) to 17% with the improved process.
Export Options
About this article
Cite this article as:
Reddy Venkata Vajrala, Naga Brahmeswara Rao Venkata Mandava, Ganesh Varanasi, Kumar Vijaya Adla, Praveen Cherukupally, Mukkanti Khagga, Reddy Mahesh Ganta and Reddy Madhusudhan Ganta, An Improved Process for the Production of Rivastigmine Tartrate, a Cholinesterase Inhibitor, Letters in Organic Chemistry 2010; 7 (2) . https://dx.doi.org/10.2174/157017810790796246
DOI https://dx.doi.org/10.2174/157017810790796246 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis
Current Medicinal Chemistry Progress and Prospects of Stem Cells in Treatment of Drug Resistant Tuberculosis
Current Respiratory Medicine Reviews The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator
Current Medicinal Chemistry Measuring the Impact of Psychoactive Substance on Health-Related Quality of Life: An Update
Current Drug Abuse Reviews Solution-Phase Parallel Synthesis of N,6-Disubstituted Isoquinuclidines as Ibogaine Analogs
Letters in Drug Design & Discovery Syntheses and Evaluation of Asymmetric Curcumin Analogues as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
Current Alzheimer Research An Investigation of the Anti-Parkinsonism Potential of Co-enzyme Q<sub>10</sub> and Co-enzyme Q<sub>10</sub> /Levodopa-carbidopa Combination in Mice
Current Aging Science “Ride or Die”: Therapeutic Interventions for Retaliatory Violence Among Youth
Adolescent Psychiatry Objective Biomarkers or Symptom Scores for the Classification of Fibromyalgia Syndrome?
Current Rheumatology Reviews Intrathecal Apelin-13 Produced Different Actions in Formalin Test and Tail-flick Test in Mice
Protein & Peptide Letters Possible Role of BDNF-Induced Microglial Intracellular Ca<sup>2+</sup> Elevation in the Pathophysiology of Neuropsychiatric Disorders
Mini-Reviews in Medicinal Chemistry Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine The Role of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis. Where are we Now?
Recent Patents on CNS Drug Discovery (Discontinued) Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimers Disease
Current Topics in Medicinal Chemistry Antagonism of Eosinophil Accumulation in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Using Protein-protein Interaction Network Information to Predict the Subcellular Locations of Proteins in Budding Yeast
Protein & Peptide Letters Low-Dose Mercury Exposure in Early Life: Relevance of Thimerosal to Fetuses, Newborns and Infants
Current Medicinal Chemistry Neuroprotective Strategies for Parkinsons Disease
Current Neuropharmacology Clinical Application of Ghrelin
Current Pharmaceutical Design Editorial [HotTopic: New and Emerging Approaches to Treatment of Schizophrenia (Guest Editors: Gene G. Kinney and P. Jeffrey Conn)]
Current Neuropharmacology